T. Rowe Price Associates, Inc. 13D and 13G filings for Repare Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | Repare Therapeutics Inc. RPTX | T. Rowe Price Associates, Inc. | 26,894 0.100% | -2,139,928 (-98.76%) | Filing |
| 2022-02-14 2:35 pm Purchase | 2021-12-31 | 13G | Repare Therapeutics Inc. RPTX | T. Rowe Price Associates, Inc. | 2,166,822 5.100% | 2,166,822 (New Position) | Filing |